Cargando…
Personalised anti-inflammatory therapy for bronchiectasis and cystic fibrosis: selecting patients for controlled trials of neutrophil elastase inhibition
BACKGROUND: Neutrophil elastase (NE) has been linked to lung neutrophil dysfunction in bronchiectasis and cystic fibrosis (CF), making NE inhibition a potential therapeutic target. NE inhibitor trials have given mixed result perhaps because not all patients have elevated airway NE activity. METHODS:...
Autores principales: | Keir, Holly R., Fong, Christopher J., Crichton, Megan L., Barth, Philip, Chevalier, Eric, Brady, Gill, Kennedy, Gwen, Zimmermann, Johann, Bruijnzeel, Piet L.B., Dicker, Alison J., Chalmers, James D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
European Respiratory Society
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6431753/ https://www.ncbi.nlm.nih.gov/pubmed/30918898 http://dx.doi.org/10.1183/23120541.00252-2018 |
Ejemplares similares
-
Neutrophil elastase in bronchiectasis
por: Gramegna, Andrea, et al.
Publicado: (2017) -
Global impact of bronchiectasis and cystic fibrosis
por: Redondo, Margarida, et al.
Publicado: (2016) -
Pulmonary rehabilitation after exacerbation of bronchiectasis: a pilot randomized controlled trial
por: Chalmers, James D., et al.
Publicado: (2019) -
Insights into Personalised Medicine in Bronchiectasis
por: Fraser, Clementine S., et al.
Publicado: (2023) -
The microbiome in bronchiectasis
por: Richardson, Hollian, et al.
Publicado: (2019)